ATTORNEY ADVERTISEMENT. Samuel L. Eilers, Esq. (CA SBN 289222), 3099 Driscoll Drive, San Diego, CA 92117
Advertising by a legal marketing service. No attorney-client relationship is formed.
Oxbryta Recall Lawsuit
Oxbryta sickle cell drug recalled after reports of deaths and complications. Patients may have claims.
Reported case value ranges (not guaranteed): Varies by injury
Results vary. Past results do not guarantee future outcomes. No compensation is guaranteed.
Symptoms & Injuries
- Vaso-occlusive crisis
- Fatal complications
- Organ damage
- Severe anemia events
Eligibility Criteria
- • Took Oxbryta ( voxelotor )
- • Serious injury or death of loved one
- • Use before 2024 recall
Lawsuit Updates
2024
Post-recall litigation emerging
Claims developing following FDA safety alerts and recall.
MDL Information
- Court
- Emerging
- Docket
- Pending
- Filed
- 2024
- Overview
- Oxbryta sickle cell drug injury claims.
FAQ
Individuals who used or were exposed to Oxbryta and suffered related injuries may qualify. Eligibility depends on usage duration, diagnosis, and state-specific deadlines.